Core Insights - The company, Zhifei Biological, announced on September 26 that it has gained control of Chanan Biological through a capital increase, expanding its business from vaccines to the field of metabolic diseases [2] Group 1 - The company has successfully completed a capital increase to acquire a controlling stake in Chanan Biological [2] - This strategic move marks the company's expansion into the metabolic disease sector, diversifying its portfolio beyond vaccines [2]